A systematic review of neurological impairments in myalgic encephalomyelitis/ chronic fatigue syndrome using neuroimaging techniques.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science

Neuroimaging*; Autonomic Nervous System/*physiopathology ; Fatigue Syndrome, Chronic/*physiopathology ; White Matter/*physiopathology; Autonomic Nervous System/diagnostic imaging ; Cerebrovascular Circulation/physiology ; Fatigue Syndrome, Chronic/diagnosis ; Gray Matter/diagnostic imaging ; Gray Matter/physiopathology ; Humans ; Severity of Illness Index ; White Matter/diagnostic imaging

Background: Myalgic encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) is a multi-system illness characterised by a diverse range of debilitating symptoms including autonomic and cognitive dysfunction. The pathomechanism remains elusive, however, neurological and cognitive aberrations are consistently described. This systematic review is the first to collect and appraise the literature related to the structural and functional neurological changes in ME/CFS patients as measured by neuroimaging techniques and to investigate how these changes may influence onset, symptom presentation and severity of the illness.
Methods: A systematic search of databases Pubmed, Embase, MEDLINE (via EBSCOhost) and Web of Science (via Clarivate Analytics) was performed for articles dating between December 1994 and August 2019. Included publications report on neurological differences in ME/CFS patients compared with healthy controls identified using neuroimaging techniques such as magnetic resonance imaging, positron emission tomography and electroencephalography. Article selection was further refined based on specific inclusion and exclusion criteria. A quality assessment of included publications was completed using the Joanna Briggs Institute checklist.
Results: A total of 55 studies were included in this review. All papers assessed neurological or cognitive differences in adult ME/CFS patients compared with healthy controls using neuroimaging techniques. The outcomes from the articles include changes in gray and white matter volumes, cerebral blood flow, brain structure, sleep, EEG activity, functional connectivity and cognitive function. Secondary measures including symptom severity were also reported in most studies.
Conclusions: The results suggest widespread disruption of the autonomic nervous system network including morphological changes, white matter abnormalities and aberrations in functional connectivity. However, these findings are not consistent across studies and the origins of these anomalies remain unknown. Future studies are required confirm the potential neurological contribution to the pathology of ME/CFS.
Competing Interests: The authors have declared that no competing interests exist.

J Magn Reson Imaging. 2016 Nov;44(5):1301-1311. (PMID: 27123773)
J Intern Med. 2011 Oct;270(4):327-38. (PMID: 21777306)
Eur J Neurosci. 2020 Apr;51(7):1642-1656. (PMID: 31408571)
Transl Psychiatry. 2016 Feb 09;6:e730. (PMID: 26859813)
Psychiatry Res. 2015 Dec 30;234(3):292-7. (PMID: 26602611)
Mol Med. 2019 Apr 23;25(1):14. (PMID: 31014226)
J Psychosom Res. 2014 Apr;76(4):286-91. (PMID: 24630178)
Radiology. 2001 Jun;219(3):766-73. (PMID: 11376266)
Psychosom Med. 2006 Nov-Dec;68(6):947-55. (PMID: 17079703)
Biol Psychiatry. 2005 Feb 1;57(3):239-46. (PMID: 15691524)
Fatigue. 2018;6(2):63-79. (PMID: 29707427)
Mod Trends Pharmacopsychiatry. 2013;28:162-74. (PMID: 25224898)
BMC Neurol. 2006 Feb 22;6:9. (PMID: 16504053)
Neuroimage. 2007 Feb 15;34(4):1438-42. (PMID: 17169580)
PLoS One. 2014 May 23;9(5):e98156. (PMID: 24858857)
Clin Physiol Funct Imaging. 2018 Jan;38(1):128-137. (PMID: 27678090)
Psychosom Med. 2003 Jan-Feb;65(1):129-36. (PMID: 12554824)
J Psychosom Res. 2009 Jan;66(1):51-7. (PMID: 19073294)
BMC Neurol. 2017 Jun 20;17(1):117. (PMID: 28633629)
Magn Reson Imaging. 2016 May;34(4):603-8. (PMID: 26708036)
Brain Imaging Behav. 2019 Jun;13(3):789-797. (PMID: 29855991)
Psychiatry Res. 2011 Aug 30;189(1):128-34. (PMID: 21196050)
J Magn Reson Imaging. 2019 Mar;49(3):818-824. (PMID: 30430664)
NMR Biomed. 2015 Mar;28(3):404-13. (PMID: 25702943)
Am J Psychiatry. 2003 Feb;160(2):221-36. (PMID: 12562565)
PLoS One. 2018 Jul 3;13(7):e0200068. (PMID: 29969498)
Neuroimage Clin. 2016 Mar 31;11:530-537. (PMID: 27114901)
J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):922-8. (PMID: 12810781)
Psychol Med. 2008 Jul;38(7):941-51. (PMID: 18447963)
Brain Imaging Behav. 2020 Apr;14(2):562-572. (PMID: 30617782)
Biol Psychol. 2018 Jul;136:87-99. (PMID: 29802861)
Biol Psychiatry. 2017 Feb 15;81(4):358-365. (PMID: 27817843)
Neuroreport. 2004 Dec 3;15(17):2571-4. (PMID: 15570154)
Br J Radiol. 2010 May;83(989):419-23. (PMID: 20223910)
JDR Clin Trans Res. 2019 Aug 28;:2380084419872135. (PMID: 31461628)
NMR Biomed. 2009 Apr;22(3):251-8. (PMID: 18942064)
Science. 2010 Nov 5;330(6005):768-9. (PMID: 21051624)
Radiology. 2015 Feb;274(2):517-26. (PMID: 25353054)
J Nucl Med. 2014 Jun;55(6):945-50. (PMID: 24665088)
Behav Brain Funct. 2009 Oct 06;5:43. (PMID: 19807920)
Ann Intern Med. 1994 Dec 15;121(12):953-9. (PMID: 7978722)
Br J Radiol. 2012 Jul;85(1015):e270-3. (PMID: 22128128)
Acta Psychiatr Scand. 2002 Sep;106(3):224-6. (PMID: 12197861)
Neuroimage. 2001 Sep;14(3):685-700. (PMID: 11506541)
Front Pediatr. 2019 Jan 08;6:412. (PMID: 30671425)
Neuroimage Clin. 2017 Sep 28;17:24-30. (PMID: 29021956)
Neuroimage. 2007 May 15;36(1):108-22. (PMID: 17408973)
Evid Based Complement Alternat Med. 2015;2015:380615. (PMID: 25792998)
Am J Physiol Heart Circ Physiol. 2009 Aug;297(2):H664-73. (PMID: 19502561)
NMR Biomed. 2011 Dec;24(10):1302-12. (PMID: 21560176)
PLoS One. 2012;7(12):e51515. (PMID: 23240035)
NMR Biomed. 2010 Jul;23(6):643-50. (PMID: 20661876)
Neuroimage Clin. 2018;20:102-109. (PMID: 30497131)
Neuroimage. 2005 Jun;26(2):513-24. (PMID: 15907308)
Neuroimage. 2019 Aug 15;197:652-656. (PMID: 30296563)
Lancet. 2006 Jan 28;367(9507):346-55. (PMID: 16443043)
Front Cell Neurosci. 2017 Sep 11;11:272. (PMID: 28959187)
Brain. 2004 Sep;127(Pt 9):1948-57. (PMID: 15240435)
Appl Psychophysiol Biofeedback. 2016 Sep;41(3):283-300. (PMID: 26869373)
Psychiatry Res. 2010 Feb 28;181(2):155-64. (PMID: 20006474)
BMC Neurol. 2004 Oct 04;4(1):14. (PMID: 15461817)
Neuropsychiatr Dis Treat. 2016 Jan 28;12:241-9. (PMID: 26869792)
Neuroimage. 2005 Jul 1;26(3):777-81. (PMID: 15955487)
NMR Biomed. 2017 Oct;30(10):. (PMID: 28661067)
Psychiatry Res. 2012 Dec 30;200(2-3):742-7. (PMID: 22771174)
J Neurol Sci. 2011 Feb 15;301(1-2):9-11. (PMID: 21167506)
J Alzheimers Dis. 2015;45(2):457-70. (PMID: 25547636)
J Sleep Res. 2018 Dec;27(6):e12703. (PMID: 29770505)
BMJ. 2000 Jan 29;320(7230):292-6. (PMID: 10650029)
Brain Connect. 2018 Feb;8(1):33-39. (PMID: 29152994)
NMR Biomed. 2012 Sep;25(9):1073-87. (PMID: 22281935)
Brain Res Cogn Brain Res. 2004 Jun;20(1):106-10. (PMID: 15130595)

Date Created: 20200501 Date Completed: 20200731 Latest Revision: 20200731

20240628

PMC7192498

10.1371/journal.pone.0232475

32353033